PFIZER INC Cash & Equivalents 2006-2025 | PFE
Beta
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is PFIZER INC's current cash & equivalents?
PFIZER INC (PFE) annual cash & equivalents for 2024 was $1.04B, a 63.44% decline from 2023. PFIZER INC cash & equivalents for the quarter ending September 28, 2025 was $1.34B.
What was PFIZER INC's cash & equivalents in 2023?
PFIZER INC annual cash & equivalents for 2023 was $2.85B, a 585.82% increase from 2022.
What was PFIZER INC's cash & equivalents in 2022?
PFIZER INC annual cash & equivalents for 2022 was $416.0M, a 78.60% decline from 2021.
What is PFIZER INC's 5-year cash & equivalents CAGR?
PFIZER INC cash & equivalents grew at a compound annual growth rate (CAGR) of 1.43% from FY2019 to FY2024, going from $1.12B to $1.04B over 5 years.
Cash & Equivalents History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-1.4%
FY2019
$1.12B
→
FY2024
$1.04B
06070809101112131415161718192021222324
5 years selected
Cash & Equivalents History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $1.04B | -63.4% | 10-K |
| FY2023 | $2.85B | +585.8% | 10-K |
| FY2022 | $416.0M | -78.6% | 10-K |
| FY2021 | $1.94B | +8.8% | 10-K |
| FY2020 | $1.79B | +59.3% | 10-K |
| FY2019 | $1.12B | -1.6% | 10-K |
| FY2018 | $1.14B | -15.1% | 10-K |
| FY2017 | $1.34B | -48.3% | 10-K |
| FY2016 | $2.60B | -28.7% | 10-K |
| FY2015 | $3.64B | +8.9% | 10-K |
| FY2014 | $3.34B | +53.1% | 10-K |
| FY2013 | $2.18B | -78.3% | 10-K |
| FY2012 | $10.08B | +216.8% | 10-K |
| FY2011 | $3.18B | +83.4% | 10-K |
| FY2010 | $1.74B | -12.3% | 10-K |
| FY2009 | $1.98B | -6.8% | 10-K |
| FY2008 | $2.12B | -37.7% | 10-K |
| FY2007 | $3.41B | +86.4% | 10-K |
| FY2006 | $1.83B | - | 10-K |
Company: PFIZER INCTicker: PFESector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →